Darwin Global Management, Ltd. Vir Biotechnology, Inc. Transaction History

Darwin Global Management, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $3.09 Million - $5.84 Million	-145,841 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $3.11 Million - $5.43 Million	100,530 Added 221.87%	145,841 $6.11 Million
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $1.58 Million - $2.47 Million	45,311 New	45,311 $1.97 Million

225

87.5M

231K

132K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.23B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Darwin Global Management, Ltd. with notifications on news.